Nasdaq · Biotech stocks database
MXCT (MaxCyte Inc.) stock: $1.26, $130.0M market cap, $105.7M cash, $24.3M EV, $149.4M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
We are a leading commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics including cell and gene therapies and to support innovative cell-based research and development.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $105.7M |
|---|---|
| Debt | $0.0M |
| Net cash | $105.7M |
| Enterprise value | $24.3M |
| Basic shares | 103.2M shares |
| Fully diluted shares | 118.6M shares |
| Fully diluted market cap | $149.4M |
| Cash per share | $1.02 |
| Quarterly burn | $4.7M |
| Cash runway | 22.7 quarters |
Cash figures as of 2026-06-30. Database snapshot: 2026-11-07.
Cap table as of 2026-08-07.
Loading MXCT daily closes…